<DOC>
	<DOC>NCT00185120</DOC>
	<brief_summary>A comparison of 2 different combinations of high blood pressure medications to treat hypertension</brief_summary>
	<brief_title>Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Greater than 18 years of age Patients with high blood pressure Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>angiotensin receptor blocker</keyword>
	<keyword>calcium channel blocker</keyword>
	<keyword>angiotensin converting enzyme inhibitor hydroclorothiazide</keyword>
</DOC>